Cellular targets and molecular activity mechanisms of bee venom in cancer: recent trends and developments

References

• Aggarwal, V., et al., 2019. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules, 9 (11), 735.
   PubMed Web of Science ®Google Scholar
• Alalawy, A.I., et al., 2020. Effectual anticancer potentiality of loaded bee venom onto fungal chitosan nanoparticles. International journal of polymer science, 2020, 1–9.
   Web of Science ®Google Scholar
• Ali, M., 2012. Studies on bee venom and its medical uses. International journal of advanced research Technol, 1, 69–83.
   Google Scholar
• Alizadehnohi, M., et al., 2012. The synergistic cytotoxic effect of cisplatin and honey bee venom on human ovarian cancer cell line A2780cp. Journal of venom research, 3, 22–27.
   PubMedGoogle Scholar
• Almunia, C., et al., 2013. Bee venom phospholipase A2, a good “chauffeur” for delivering tumor antigen to the MHC I and MHC II peptide-loading compartments of the dendritic cells: the case of NY-ESO-1. PLOS One, 8 (6), e67645.
   PubMed Web of Science ®Google Scholar
• Amin, M., Abdel-Raheem, I., and Madkor, H., 2008. Wound healing and anti-inflammatory activities of bee venom-chitosan blend films. Journal of drug delivery science and technology, 18 (6), 424–430.
   Web of Science ®Google Scholar
• An, H.-J., et al., 2016. The protective effect of melittin on renal fibrosis in an animal model of unilateral ureteral obstruction. Molecules, 21 (9), 1137.
   PubMed Web of Science ®Google Scholar
• Bačkorová, M., et al., 2012. Lichen secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 human cancer cell lines. Toxicology in vitro, 26 (3), 462–468.
   PubMed Web of Science ®Google Scholar
• Badr-Eldin, S.M., et al., 2020. Cytotoxic and pro-apoptotic effects of a sub-toxic concentration of fluvastatin on OVCAR3 ovarian cancer cells after its optimized formulation to melittin nano-conjugates. Frontiers in pharmacology, 11, 642171.
   PubMed Web of Science ®Google Scholar
• Badr, G., et al., 2016. Bee venom accelerates wound healing in diabetic mice by suppressing activating transcription factor-3 (ATF-3) and inducible nitric oxide synthase (iNOS)-mediated oxidative stress and recruiting bone marrow-derived endothelial progenitor cells. Journal of cellular physiology, 231 (10), 2159–2171.
   PubMed Web of Science ®Google Scholar
• Badria, F., et al., 2017. Evaluate the cytotoxic activity of honey, propolis, and bee venom from different localities in Egypt against liver, breast, and colorectal cancer. Journal of apitherapy, 2 (1), 1–4.
   Google Scholar
• Bae, G.-S., et al., 2013. Apamin attenuated cerulein-induced acute pancreatitis by inhibition of JNK pathway in mice. Digestive diseases and sciences, 58 (10), 2908–2917.
   PubMed Web of Science ®Google Scholar
• Bagyalakshmi, B., Priyadarshini, S.L., and Balamurugan, A., 2019. Anticancer activity of bee venom against lung cancer cell line (A549 cells) enhanced by iron oxide nanoparticles synthesized from Syzygium aromaticum. Journal of drug delivery and therapeutics, 9, 248–254.
   Google Scholar
• Bellik, Y., 2015. Bee venom: its potential use in alternative medicine. Anti-infective agents, 13 (1), 3–16.
   Google Scholar
• Bray, F., et al., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A cancer journal for clinicians, 68 (6), 394–424.
   PubMed Web of Science ®Google Scholar
• Celis, J.E., and Heitor, M., 2019. Towards a mission-oriented approach to cancer in Europe: an unmet need in cancer research policy. Molecular oncology, 13 (3), 502–510.
   PubMed Web of Science ®Google Scholar
• Chen, J., and Guan, S.-M., 2017. Bee Venom and Pain. In: L.J. Cruz, S. Luo and P. Gopalakrishnakone, eds. Toxins and drug discovery. Dordrecht: Springer Netherlands, 253–294.
   Google Scholar
• Chen, J., and Lariviere, W.R., 2010. The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword. Progress in neurobiology, 92 (2), 151–183.
   PubMed Web of Science ®Google Scholar
• Cho, H.-J., et al., 2010. Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms. Journal of ethnopharmacology, 127 (3), 662–668.
   PubMed Web of Science ®Google Scholar
• Choi, K.E., et al., 2014. Cancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells. Toxins, 6 (8), 2210–2228.
   PubMed Web of Science ®Google Scholar
• Cichocka-Jarosz, E., 2012. Hymenoptera venom allergy in humans. Folia Medica Cracoviensia, 52, 43-60.
   PubMedGoogle Scholar
• Cooney, J., et al., 2011. Benefits of exercise in rheumatoid arthritis. Journal of aging research, 2011, 1–14.
   Google Scholar
• Davies, J., et al., 2019. Recent developments in advanced imaging in gout. Therapeutic advances in musculoskeletal disease, 11, 1759720X19844429.
   PubMed Web of Science ®Google Scholar
• El Bakary, N.M., et al., 2020. Role of bee venom and melittin on restraining angiogenesis and metastasis in γ-irradiated solid Ehrlich carcinoma-bearing mice. Integrative cancer therapies, 19, 1534735420944476.
   Web of Science ®Google Scholar
• Fujita, Y., Abe, R., and Shimizu, H., 2008. Clinical approaches toward tumor angiogenesis: past, present and future. Current pharmaceutical design, 14 (36), 3820–3834.
   PubMed Web of Science ®Google Scholar
• Gajski, G., and Garaj-Vrhovac, V., 2009. Radioprotective effects of honeybee venom (Apis mellifera) against 915-mhz microwave radiation-induced DNA damage in Wistar rat lymphocytes: in vitro study. International journal of toxicology, 28 (2), 88–98.
   PubMed Web of Science ®Google Scholar
• Gajski, G., and Garaj-Vrhovac, V., 2011. Bee venom induced cytogenetic damage and decreased cell viability in human white blood cells after treatment in vitro: a multi-biomarker approach. Environmental toxicology and pharmacology, 32 (2), 201–211.
   PubMed Web of Science ®Google Scholar
• Gao, J., et al., 2016. RGD-modified lipid disks as drug carriers for tumor targeted drug delivery. Nanoscale, 8 (13), 7209–7216.
   PubMed Web of Science ®Google Scholar
• Glass, C.K., et al., 2010. Mechanisms underlying inflammation in neurodegeneration. Cell, 140 (6), 918–934.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and Folkman, J., 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86 (3), 353–364.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and Weinberg, R.A., 2000. The hallmarks of cancer. Cell, 100 (1), 57–70.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and Weinberg, R.A., 2011. Hallmarks of cancer: the next generation. Cell, 144 (5), 646–674.
   PubMed Web of Science ®Google Scholar
• Hatef, M., and Balali-Mood, M., 1995. Collection and standardization of honey bee venom in Iran. Journal of natural toxins, 4, 139.
   Google Scholar
• Hematyar, M., et al., 2018. Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC-MS/MS. Artificial cells, nanomedicine, and biotechnology, 46 (sup3), S1226–S1235.
   PubMed Web of Science ®Google Scholar
• Hong, S.-J., et al., 2005. Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon, 46 (1), 39–45.
   PubMed Web of Science ®Google Scholar
• Huh, J.-E., et al., 2010. Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice. Cancer letters, 292 (1), 98–110.
   PubMed Web of Science ®Google Scholar
• Huh, J.-E., et al., 2012. Melittin suppresses VEGF-A-induced tumor growth by blocking VEGFR-2 and the COX-2-mediated MAPK signaling pathway. Journal of natural products, 75 (11), 1922–1929.
   PubMed Web of Science ®Google Scholar
• Ip, S.-W., et al., 2008. Bee venom induced cell cycle arrest and apoptosis in human cervical epidermoid carcinoma Ca Ski cells. Anticancer research, 28, 833–842.
   PubMed Web of Science ®Google Scholar
• Jallouk, A.P., et al., 2015. Delivery of a protease-activated cytolytic peptide prodrug by perfluorocarbon nanoparticles. Bioconjugate chemistry, 26 (8), 1640–1650.
   PubMed Web of Science ®Google Scholar
• Jang, H.-S., et al., 2005. Effects of bee venom on the pro-inflammatory responses in RAW264.7 macrophage cell line. Journal of ethnopharmacology, 99 (1), 157–160.
   PubMed Web of Science ®Google Scholar
• Jeong, Y.-J., et al., 2019. Bee venom suppresses egf-induced epithelial-mesenchymal transition and tumor invasion in lung cancer cells. The American journal of chinese medicine, 47 (8), 1869–1883.
   PubMed Web of Science ®Google Scholar
• Jin, H., et al., 2017. Melittin-containing hybrid peptide hydrogels for enhanced photothermal therapy of glioblastoma. ACS applied materials & interfaces, 9 (31), 25755–25766.
   PubMed Web of Science ®Google Scholar
• Jo, M., et al., 2012. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicology and applied pharmacology, 258 (1), 72–81.
   PubMed Web of Science ®Google Scholar
• Jones, S.L., Jones, H.R., and Thrasyvoulou, A., 2011. Disseminating research about bee products. A review of articles published in the journal of apicultural research over the past fifty years. Journal of apiproduct & apimedical science, 3 (3), 105–116.
   Google Scholar
• Kim, J.-Y., et al., 2017. Apamin suppresses biliary fibrosis and activation of hepatic stellate cells. International journal of molecular medicine, 39 (5), 1188–1194.
   PubMed Web of Science ®Google Scholar
• Kim, J.-Y., Leem, J., and Hong, H.-L., 2021. Melittin ameliorates endotoxin-induced acute kidney injury by inhibiting inflammation, oxidative stress, and cell death in mice. Oxidative medicine and cellular longevity, 2021, 8843051.
   PubMed Web of Science ®Google Scholar
• Kim, S.-J., et al., 2012. The protective effect of apamin on LPS/fat-induced atherosclerotic mice. Evidence-based complementary and alternative medicine, 2012, 305454.
   PubMed Web of Science ®Google Scholar
• Kim, S.H., et al., 2013. Bee venom effects on ubiquitin proteasome system in hSOD1 G85R-expressing NSC34 motor neuron cells. BMC complementary and alternative medicine, 13 (1), 179.
   PubMedGoogle Scholar
• Kim, W.-H., et al., 2018. Anti-inflammatory effect of melittin on Porphyromonas gingivalis LPS-stimulated human keratinocytes. Molecules, 23 (2), 332.
   PubMed Web of Science ®Google Scholar
• Kim, Y., et al., 2019. Bee venom alleviates atopic dermatitis symptoms through the upregulation of decay-accelerating factor (DAF/CD55). Toxins, 11 (5), 239.
   PubMed Web of Science ®Google Scholar
• Koburova, K., Michailova, S., and Shkenderov, S., 1985. Further investigation on the antiinflammatory properties of adolapin–bee venom polypeptide. Acta Physiologica et Pharmacologica Bulgarica, 11 (2), 50–55.
   PubMedGoogle Scholar
• Kocyigit, A., Guler, E.M., and Kaleli, S., 2019. Anti-inflammatory and antioxidative properties of honey bee venom on Freund's complete adjuvant-induced arthritis model in rats. Toxicon, 161, 4–11.
   PubMed Web of Science ®Google Scholar
• Koh, P.S., et al., 2013. Clinical effectiveness of bee venom acupuncture and physiotherapy in the treatment of adhesive capsulitis: a randomized controlled trial. Journal of shoulder and elbow surgery, 22 (8), 1053–1062.
   PubMed Web of Science ®Google Scholar
• Kollipara, P.S., et al., 2014. Co-culture with NK-92MI cells enhanced the anti-cancer effect of bee venom on NSCLC cells by inactivation of NF-κB. Archives of pharmacal research, 37 (3), 379–389.
   PubMed Web of Science ®Google Scholar
• Kong, G.-M., et al., 2016. Melittin induces human gastric cancer cell apoptosis via activation of mitochondrial pathway. World journal of gastroenterology, 22 (11), 3186.
   PubMed Web of Science ®Google Scholar
• Kurek-Górecka, A., et al., 2020. Bee venom in wound healing. Molecules, 26 (1), 148.
   PubMed Web of Science ®Google Scholar
• Kwon, Y.B., et al., 2002. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sciences, 71 (2), 191–204.
   PubMed Web of Science ®Google Scholar
• Lai, H., et al., 2017. Polypeptide-grafted nanodiamonds for controlled release of melittin to treat breast cancer. ACS macro letters, 6 (8), 796–801.
   Web of Science ®Google Scholar
• Lee, G., and Bae, H., 2016a. Anti-inflammatory applications of melittin, a major component of bee venom: detailed mechanism of action and adverse effects. Molecules, 21 (5), 616.
   PubMed Web of Science ®Google Scholar
• Lee, G., and Bae, H., 2016b. Bee venom phospholipase A2: yesterday's enemy becomes today's friend. Toxins, 8 (2), 48.
   PubMed Web of Science ®Google Scholar
• Lee, J.-D., et al., 2005. An overview of bee venom acupuncture in the treatment of arthritis. Evidence-based complementary and alternative medicine, 2 (1), 79–84.
   PubMed Web of Science ®Google Scholar
• Lee, W.-R., et al., 2014. The protective effects of melittin on propionibacterium acnes-induced inflammatory responses in vitro and in vivo. The journal of investigative dermatology, 134 (7), 1922–1930.
   PubMed Web of Science ®Google Scholar
• Lee, Y.J., et al., 2020a. Anti-inflammatory effect of bee venom in phthalic anhydride-induced atopic dermatitis animal model. Inflammopharmacology, 28 (1), 253–263.
   PubMed Web of Science ®Google Scholar
• Lee, Y.M., et al., 2020b. Apamin from bee venom suppresses inflammation in a murine model of gouty arthritis. Journal of ethnopharmacology, 257, 112860.
   PubMed Web of Science ®Google Scholar
• Lin, T.-Y., and Hsieh, C.-L., 2020. Clinical applications of bee venom acupoint injection. Toxins, 12 (10), 618.
   PubMed Web of Science ®Google Scholar
• Liu, C.-C., et al., 2016. Application of bee venom and its main constituent melittin for cancer treatment. Cancer chemotherapy and pharmacology, 78 (6), 1113–1130.
   PubMed Web of Science ®Google Scholar
• Liu, H., et al., 2019. Co-delivery of bee venom melittin and a photosensitizer with an organic-inorganic hybrid nanocarrier for photodynamic therapy and immunotherapy. ACS Nano, 13 (11), 12638–12652.
   PubMed Web of Science ®Google Scholar
• Liu, S., et al., 2008. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology, 47 (6), 1964–1973.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2002. Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo. The journal of pharmacy and pharmacology, 54 (8), 1083–1089.
   PubMed Web of Science ®Google Scholar
• Lokeshwar, V.B., and Selzer, M.G., 2009. Hyaluronidase: both a tumor promoter and suppressor. Hyaluronan in cancer biology, Academic Press, Cambridge, Massachusetts, USA, 189–206.
   Google Scholar
• Maher, S., and Mcclean, S., 2008. Melittin exhibits necrotic cytotoxicity in gastrointestinal cells which is attenuated by cholesterol. Biochemical pharmacology, 75 (5), 1104–1114.
   PubMed Web of Science ®Google Scholar
• Mansoori, B., et al., 2017. The different mechanisms of cancer drug resistance: a brief review. Advanced pharmaceutical bulletin, 7 (3), 339–348.
   PubMed Web of Science ®Google Scholar
• Matusiewicz, M., et al., 2014. Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases. Disease markers, 2014, 643645.
   PubMed Web of Science ®Google Scholar
• Mcatee, C.O., Barycki, J.J., and Simpson, M.A., 2014. Emerging roles for hyaluronidase in cancer metastasis and therapy. Advances in cancer research, 123, 1–34.
   PubMed Web of Science ®Google Scholar
• Moghaddam, F.D., et al., 2020. Delivery of melittin loaded niosomes for breast cancer treatment: an in-vitro and in-vivo evaluation of anti-cancer effect.
   Google Scholar
• Mohamed, W.A., Abd-Elhakim, Y.M., and Ismail, S.A., 2019. Involvement of the anti-inflammatory, anti-apoptotic, and anti-secretory activity of bee venom in its therapeutic effects on acetylsalicylic acid-induced gastric ulceration in rats. Toxicology, 419, 11–23.
   PubMed Web of Science ®Google Scholar
• Mohammadi-Rad, M., Ghasemi, N., and Aliomrani, M., 2019. Evaluation of apamin effects on myelination process in C57BL/6 mice model of multiple sclerosis. Research in pharmaceutical sciences, 14 (5), 424–431.
   PubMed Web of Science ®Google Scholar
• Moon, D.-O., et al., 2006. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. International immunopharmacology, 6 (12), 1796–1807.
   PubMed Web of Science ®Google Scholar
• Mueller, U.R., 2007. Cardiovascular disease and anaphylaxis. Current opinion in allergy and clinical immunology, 7 (4), 337–341.
   PubMed Web of Science ®Google Scholar
• Ong, P.Y., and Leung, D.Y., 2016. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clinical reviews in allergy & immunology, 51 (3), 329–337.
   PubMed Web of Science ®Google Scholar
• Oršolić, N., 2009. Potentiation of bleomycin lethality in HeLa and V79 cells by bee venom. Archives of industrial hygiene and toxicology, 60 (3), 317–326.
   PubMed Web of Science ®Google Scholar
• Oršolić, N., 2012. Bee venom in cancer therapy. Cancer metastasis reviews, 31 (1–2), 173–194.
   PubMed Web of Science ®Google Scholar
• Ozturk, A., et al., 2017. Comparison of inflammatory cytokine release from nasal epithelial cells of non-atopic non-rhinitic, allergic rhinitic and polyp subjects and effects of diesel exhaust particles in vitro. Allergologia et Immunopathologia, 45 (5), 473–481.
   PubMed Web of Science ®Google Scholar
• Pan, H., et al., 2011. Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy. wiley interdisciplinary reviews-nanomedicine and nanobiotechnology, 3 (3), 318–327.
   PubMed Web of Science ®Google Scholar
• Park, H.G., et al., 2018a. Honeybee (Apis cerana) vitellogenin acts as an antimicrobial and antioxidant agent in the body and venom. Developmental and comparative immunology, 85, 51–60.
   PubMed Web of Science ®Google Scholar
• Park, H.J., et al., 2004. Antiarthritic effect of bee venom: Inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis and rheumatism, 50 (11), 3504–3515.
   PubMed Web of Science ®Google Scholar
• Park, H.J., et al., 2007. Melittin inhibits inflammatory target gene expression and mediator generation via interaction with IkappaB kinase. Biochemical pharmacology, 73 (2), 237–247.
   PubMed Web of Science ®Google Scholar
• Park, J.H., et al., 2010. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Molecules and cells, 29 (2), 209–215.
   PubMed Web of Science ®Google Scholar
• Park, J.H., et al., 2015. Risk associated with bee venom therapy: a systematic review and meta-analysis. PLOS one, 10 (5), e0126971.
   PubMed Web of Science ®Google Scholar
• Park, M.-H., et al., 2018b. Preparation and characterization of bee venom-loaded PLGA particles for sustained release. Pharmaceutical development and technology, 23 (9), 857–864.
   PubMed Web of Science ®Google Scholar
• Pascoal, A., et al., 2019. An overview of the bioactive compounds, therapeutic properties and toxic effects of apitoxin. Food and chemical toxicology,134, 110864–110811.
   PubMed Web of Science ®Google Scholar
• Pavel, C.I., et al., 2014. Comparison between local and commercial royal jelly—use of antioxidant activity and 10-hydroxy-2-decenoic acid as quality parameter. Journal of apicultural research, 53 (1), 116–123.
   Web of Science ®Google Scholar
• Pucca, M.B., et al., 2019. Bee updated: Current knowledge on bee venom and bee envenoming therapy. Frontiers in immunology, 10, 2090.
   PubMed Web of Science ®Google Scholar
• Qi, J., et al., 2020. Graphene oxide-based magnetic nanocomposites for the delivery of melittin to cervical cancer HeLa cells. Nanotechnology, 31 (6), 065102.
   PubMed Web of Science ®Google Scholar
• Rady, I., et al., 2017. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer letters, 402, 16–31.
   PubMed Web of Science ®Google Scholar
• Raghuraman, H., and Chattopadhyay, A., 2007. Melittin: a membrane-active peptide with diverse functions. Bioscience reports, 27 (4–5), 189–223.
   PubMed Web of Science ®Google Scholar
• Rojiani, M.V., et al., 2010. Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma. International journal of clinical and experimental pathology, 3 (8), 775–781.
   PubMed Web of Science ®Google Scholar
• Safaeinejad, Z., Nabiuni, M., and Nazari, Z., 2013. Potentiation of a novel palladium (II) complex lethality with bee venom on the human T-cell acute lymphoblastic leukemia cell line (MOLT-4). Journal of venomous animals and toxins including tropical diseases, 19 (1), 25.
   PubMed Web of Science ®Google Scholar
• Shin, B.-C., et al., 2012. Bee venom acupuncture for chronic low back pain: a randomised, sham-controlled, triple-blind clinical trial. European journal of integrative medicine, 4 (3), e271–e280.
   Web of Science ®Google Scholar
• Shin, D., Choi, W., and Bae, H., 2018. Bee venom phospholipase A2 alleviate house dust mite-induced atopic dermatitis-like skin lesions by the CD206 mannose receptor. Toxins, 10 (4), 146.
   PubMed Web of Science ®Google Scholar
• Sisakht, M., et al., 2017. Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells. Revista Brasileira de Farmacognosia, 27 (3), 324–328.
   Google Scholar
• Son, D.J., et al., 2007. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacology & therapeutics, 115 (2), 246–270.
   PubMed Web of Science ®Google Scholar
• Stuhlmeier, K.M., 2007. Apis mellifera venom and melittin block neither NF-kappa B-p50-DNA interactions nor the activation of NF-kappa B, instead they activate the transcription of proinflammatory genes and the release of reactive oxygen intermediates. Journal of immunology, 179 (1), 655–664.
   PubMed Web of Science ®Google Scholar
• Tu, W.-C., et al., 2008. Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells. Toxicon, 52 (2), 318–329.
   PubMed Web of Science ®Google Scholar
• Ulus, G., et al., 2018. The anti-angiogenic potential of (±) gossypol in comparison to suramin. Cytotechnology, 70 (6), 1537–1550.
   PubMed Web of Science ®Google Scholar
• Varinska, L., et al., 2010. Antiangogenic effect of selected phytochemicals. Die Pharmazie-an international journal of pharmaceutical sciences, 65, 57–63.
   Google Scholar
• Varol, M., 2016. The importance of metal-based drugs in medicinal inorganic chemistry to improve life quality of patients. Journal of applied pharmacy, 08 (01), 2.
   Google Scholar
• Varol, M., 2017. Angiogenesis as an important target in cancer therapies. In: A.A. Hasan Arapgirlioglu, Robert L. Elliott, and Edward Turgeon, eds. Researches on science and art in 21st century Turkey. Turkey: Gece Publishing, 1971–1981.
   Google Scholar
• Varol, M., 2018. Anti-breast cancer and anti-angiogenic potential of a lichen-derived small-molecule: barbatolic acid. Cytotechnology, 70 (6), 1565–1573.
   PubMed Web of Science ®Google Scholar
• Varol, M., 2019a. Lichens as a promising source of unique and functional small molecules for human health and well-being. Studies in natural products chemistry. Elsevier, Amsterdam, 425–458.
   Google Scholar
• Varol, M., 2019b. Parietin as an efficient and promising anti-angiogenic and apoptotic small-molecule from Xanthoria parietina. Revista Brasileira de Farmacognosia, 29 (6), 728–734.
   Google Scholar
• Varol, M., 2020a. Natural remedies and functional foods as angiogenesis modulators. Functional foods in cancer prevention and therapy. Elsevier, Amsterdam, 1–31.
   Google Scholar
• Varol, M., 2020b. ROS and oxidative stress in cancer: recent advances. Drug targets in cellular processes of cancer: from nonclinical to preclinical models, Springer, Singapore, 109–138.
   Google Scholar
• Wattanakul, K., et al., 2019. Oligopeptide-side chained alginate nanocarrier for melittin-targeted chemotherapy. Polymer journal, 51 (8), 771–780.
   Web of Science ®Google Scholar
• Wehbe, R., et al., 2019. Bee venom: overview of main compounds and bioactivities for therapeutic interests. Molecules, 24 (16), 2997.
   PubMed Web of Science ®Google Scholar
• WHO, 2020. WHO report on cancer: setting priorities, investing wisely and providing care for all. World Health Organization, Geneva. https://apps.who.int/iris/handle/10665/330745.
   Google Scholar
• Wu, X., et al., 2015. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells. Toxicology and applied pharmacology, 288 (1), 74–83.
   PubMed Web of Science ®Google Scholar
• Yazdian-Robati, R., et al., 2019. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo. Drug development and industrial pharmacy, 45 (4), 603–610.
   PubMed Web of Science ®Google Scholar
• You, C.E., et al., 2016. Effects of emollient containing bee venom on atopic dermatitis: a double-blinded, randomized, base-controlled, multicenter study of 136 patients. Annals of dermatology, 28 (5), 593–599.
   PubMed Web of Science ®Google Scholar
• You, W., and Henneberg, M., 2018. Cancer incidence increasing globally: the role of relaxed natural selection. Evolutionary applications, 11 (2), 140–152.
   PubMed Web of Science ®Google Scholar
• Zhang, H., et al., 2014. Melittin restores PTEN expression by down-regulating HDAC2 in human hepatocelluar carcinoma HepG2 cells. PloS one, 9 (5), e95520.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., et al., 2016. Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma. Oncology letters, 11 (1), 610–618.
   PubMed Web of Science ®Google Scholar
• Zhu, H., et al., 2014. Melittin radiosensitizes esophageal squamous cell carcinoma with induction of apoptosis in vitro and in vivo. Tumour biology, 35 (9), 8699–8705.
   PubMedGoogle Scholar